{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:16:31Z","timestamp":1792826191235,"version":"4.5.0"},"reference-count":63,"publisher":"Oxford University Press (OUP)","issue":"16","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Sugammadex rapidly and effectively reverses aminosteroidal neuromuscular blocking agents and has largely replaced neostigmine in perioperative practice. Although its use is associated with faster recovery and a lower rate of residual neuromuscular blockade, clinically important limitations exist. This review summarizes the literature describing incomplete reversal, recurrence of neuromuscular blockade, adverse effects, drug interactions, and challenges in special populations, with a focus on the role of quantitative neuromuscular monitoring and pharmacist-led activities to optimize sugammadex use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>While sugammadex substantially reduces the risk of residual neuromuscular blockade compared to neostigmine, incomplete reversal and recurrence of neuromuscular blockade continue to occur, particularly when dosing is not guided by quantitative neuromuscular monitoring. Underdosing, redistribution of neuromuscular blocking agents, and altered pharmacokinetics can all contribute to inconsistent responses. Quantitative neuromuscular monitoring, rather than choice of reversal agent, is the main determinant of reliable neuromuscular recovery and reduced occurrence of postoperative complications. Sugammadex is associated with rare but potentially serious adverse effects, including hypersensitivity reactions and cardiovascular instability, highlighting the need for careful monitoring. Patent expiration and generic availability may expand access to sugammadex, and these limitations warrant continued attention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Sugammadex represents a major advance in neuromuscular blockade reversal but remains an imperfect agent. Safe and effective use requires individualized dosing guided by quantitative neuromuscular monitoring and vigilance for adverse effects. Pharmacists are well positioned to lead education, dosing protocol development, and monitoring strategies that optimize patient safety while supporting adoption of quantitative neuromuscular monitoring.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajhp\/zxag094","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T12:39:27Z","timestamp":1774096767000},"page":"835-844","source":"Crossref","is-referenced-by-count":1,"title":["Beyond the hype: Understanding the limitations of sugammadex"],"prefix":"10.1093","volume":"83","author":[{"given":"Dustin D","family":"Linn","sequence":"first","affiliation":[{"name":"Philips North America , Cambridge, MA , and , Fort Wayne, IN ,","place":["USA"]},{"name":"Department of Pharmacy, Parkview Health , Cambridge, MA , and , Fort Wayne, IN ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Ross","family":"Renew","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, Mayo Clinic College of Medicine and Science , Jacksonville, FL ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorin J","family":"Brull","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, Mayo Clinic College of Medicine and Science , Jacksonville, FL , , and , Debrecen ,","place":["USA Hungary"]},{"name":"Ed\u00f6m\u00e9r Tassonyi Neuromuscular Research Group , Jacksonville, FL , , and , Debrecen ,","place":["USA Hungary"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"issue":"5","key":"2026080419562877200_zxag094-B1","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1213\/ANE.0000000000005080","article-title":"Utilization patterns of perioperative neuromuscular blockade reversal in the United States: a retrospective observational study from the Multicenter Perioperative Outcomes Group","volume":"131","author":"Dubovoy","year":"2020","journal-title":"Anesth Analg"},{"issue":"3","key":"2026080419562877200_zxag094-B2","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/ALN.0000000000005880","article-title":"Changes in intraoperative rocuronium dosing following the introduction of sugammadex and association with postoperative respiratory complications: a retrospective cohort study","volume":"144","author":"Wachtendorf","year":"2026","journal-title":"Anesthesiology"},{"issue":"1","key":"2026080419562877200_zxag094-B3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/ALN.0000000000004379","article-title":"2023 American Society of Anesthesiologists practice guidelines for monitoring and antagonism of neuromuscular blockade: a report by the American Society of Anesthesiologists Task Force on Neuromuscular Blockade","volume":"138","author":"Thilen","year":"2023","journal-title":"Anesthesiology"},{"issue":"2","key":"2026080419562877200_zxag094-B4","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/EJA.0000000000001769","article-title":"Peri-operative management of neuromuscular blockade: a guideline from the European Society of Anaesthesiology and Intensive Care","volume":"40","author":"Fuchs-Buder","year":"2023","journal-title":"Eur J Anaesthesiol"},{"issue":"9","key":"2026080419562877200_zxag094-B5","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/j.1365-2044.2012.07197.x","article-title":"A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery","volume":"67","author":"Geldner","year":"2012","journal-title":"Anaesthesia"},{"issue":"3","key":"2026080419562877200_zxag094-B6","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/ALN.0000000000004630","article-title":"Joint letter to the editor from the American Society of Anesthesiologists and the European Society of Anaesthesiology and Intensive Care on management of neuromuscular blockade","volume":"139","author":"Fuchs-Buder","year":"2023","journal-title":"Anesthesiology"},{"issue":"5","key":"2026080419562877200_zxag094-B7","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1093\/ajhp\/zxaf213","article-title":"Postoperative benefits of sugammadex: a narrative review","volume":"83","author":"Linn","year":"2026","journal-title":"Am J Health-Syst Pharm"},{"key":"2026080419562877200_zxag094-B8","doi-asserted-by":"publisher","first-page":"e6329","DOI":"10.1136\/bmj.e6329","article-title":"Intermediate acting non-depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study","volume":"345","author":"Grosse-Sundrup","year":"2012","journal-title":"BMJ"},{"issue":"6","key":"2026080419562877200_zxag094-B9","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1097\/ALN.0000000000000674","article-title":"Dose-dependent association between intermediate-acting neuromuscular-blocking agents and postoperative respiratory complications","volume":"122","author":"McLean","year":"2015","journal-title":"Anesthesiology"},{"issue":"4","key":"2026080419562877200_zxag094-B10","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1097\/ALN.0000000000001279","article-title":"Nondepolarizing neuromuscular blocking agents, reversal, and risk of postoperative pneumonia","volume":"125","author":"Bulka","year":"2016","journal-title":"Anesthesiology"},{"issue":"2","key":"2026080419562877200_zxag094-B11","first-page":"266","article-title":"A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host","volume":"41","author":"Bom","year":"2002","journal-title":"Agnew Chem Int Ed Engl"},{"issue":"12","key":"2026080419562877200_zxag094-B12","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/ajhp\/zxz073","article-title":"ASHP guidelines on perioperative pharmacy services","volume":"76","author":"Bickham","year":"2019","journal-title":"Am J Health-Syst Pharm"},{"issue":"12","key":"2026080419562877200_zxag094-B13","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1097\/EJA.0000000000000082","article-title":"Failure of sugammadex to reverse rocuronium-induced neuromuscular blockade: a case report","volume":"31","author":"Ortiz-G\u00f3mez","year":"2014","journal-title":"Eur J Anaesthesiol"},{"issue":"1","key":"2026080419562877200_zxag094-B14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/ALN.0b013e3182580409","article-title":"Sugammadex ideal body weight dose adjusted by level of neuromuscular blockade in laparoscopic bariatric surgery","volume":"117","author":"Llaurad\u00f3","year":"2012","journal-title":"Anesthesiology"},{"issue":"19","key":"2026080419562877200_zxag094-B15","doi-asserted-by":"publisher","first-page":"e575","DOI":"10.1093\/ajhp\/zxae124","article-title":"The impact of sugammadex dosing and administration practices on potential cost savings for pharmacy departments","volume":"81","author":"Linn","year":"2024","journal-title":"Am J Health-Syst Pharm"},{"issue":"2","key":"2026080419562877200_zxag094-B16","doi-asserted-by":"publisher","first-page":"e12262","DOI":"10.1002\/anr3.12262","article-title":"Potential interaction between exogenous anabolic steroids and sugammadex: failed reversal of rocuronium in a patient taking testosterone and trestolone acetate","volume":"11","author":"Farkas","year":"2023","journal-title":"Anaesth Rep"},{"issue":"2","key":"2026080419562877200_zxag094-B17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1213\/ANE.0b013e3182999672","article-title":"Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block","volume":"117","author":"Kotake","year":"2013","journal-title":"Anesth Analg"},{"issue":"6","key":"2026080419562877200_zxag094-B18","doi-asserted-by":"publisher","first-page":"101445","DOI":"10.1016\/j.accpm.2024.101445","article-title":"Is quantitative neuromuscular monitoring mandatory after administration of the recommended dose of sugammadex? A prospective observational study","volume":"43","author":"Koo CH, Lee S, Yim S, Bae YK, Park I, Oh AY","year":"2024","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"1","key":"2026080419562877200_zxag094-B19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/ALN.0000000000004578","article-title":"A dose-finding study of sugammadex for reversal of rocuronium in cardiac surgery patients and postoperative monitoring for recurrent paralysis","volume":"139","author":"Bowdle","year":"2023","journal-title":"Anesthesiology"},{"issue":"1","key":"2026080419562877200_zxag094-B20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12871-019-0817-4","article-title":"Usefulness of intra-operative neuromuscular blockade monitoring and reversal agents for postoperative residual neuromuscular blockade: a retrospective observational study","volume":"19","author":"Domenech","year":"2019","journal-title":"BMC Anesthesiol"},{"issue":"3","key":"2026080419562877200_zxag094-B21","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1213\/ANE.0000000000006511","article-title":"Management of muscle relaxation with rocuronium and reversal with neostigmine or sugammadex guided by quantitative neuromuscular monitoring","volume":"139","author":"Thilen","year":"2024","journal-title":"Anesth Analg"},{"issue":"1","key":"2026080419562877200_zxag094-B22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/ALN.0000000000001409","article-title":"Current status of neuromuscular reversal and monitoring: challenges and opportunities","volume":"126","author":"Brull","year":"2017","journal-title":"Anesthesiology"},{"issue":"7","key":"2026080419562877200_zxag094-B23","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1053\/j.jvca.2025.04.001","article-title":"Pro: the use of sugammadex does not preclude the need for objective neuromuscular monitoring","volume":"39","author":"Renew","year":"2025","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"3","key":"2026080419562877200_zxag094-B24","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.bja.2023.12.001","article-title":"Under-dosing and over-dosing of neuromuscular blocking drugs and reversal agents: beware of the risks","volume":"132","author":"Hunter","year":"2024","journal-title":"Br J Anaesth"},{"issue":"6","key":"2026080419562877200_zxag094-B25","doi-asserted-by":"publisher","first-page":"495","DOI":"10.4097\/kjae.2013.65.6.495","article-title":"Sugammadex: clinical development and practical use","volume":"65","author":"Fuchs-Buder","year":"2013","journal-title":"Korean J Anesthesiol"},{"key":"2026080419562877200_zxag094-B26","doi-asserted-by":"publisher","first-page":"111186","DOI":"10.1016\/j.jclinane.2023.111186","article-title":"Recurarization with magnesium sulfate administered after two minutes sugammadex reversal: a randomized, double-blind, controlled trial","volume":"89","author":"Germano-Filho","year":"2023","journal-title":"J Clin Anesth"},{"issue":"9","key":"2026080419562877200_zxag094-B27","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s12630-023-02527-x","article-title":"Postoperative recurarization after sugammadex administration in two patients who received neoadjuvant chemotherapy: case reports and literature review","volume":"70","author":"Li","year":"2023","journal-title":"Can J Anaesth"},{"issue":"1","key":"2026080419562877200_zxag094-B28","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12871-017-0429-9","article-title":"Preparing for the unexpected: special considerations and complications after sugammadex administration","volume":"17","author":"Iwasaki","year":"2017","journal-title":"BMC Anesthesiol"},{"issue":"5","key":"2026080419562877200_zxag094-B29","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1097\/00000539-199611000-00030","article-title":"A comparison of cisatracurium and atracurium: onset of neuromuscular block after bolus injection and recovery after subsequent infusion","volume":"83","author":"Mellinghoff","year":"1996","journal-title":"Anesth Analg"},{"issue":"5 Pt 1","key":"2026080419562877200_zxag094-B30","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/BF03011938","article-title":"Fasciculations, myalgia and biochemical changes following succinylcholine with atracurium and lidocaine pretreatment","volume":"44","author":"Raman","year":"1997","journal-title":"Can J Anaesth"},{"issue":"3","key":"2026080419562877200_zxag094-B31","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1213\/ANE.0000000000006722","article-title":"Improving neuromuscular monitoring through education-based interventions and studying its association with adverse postoperative outcomes: a retrospective observational study","volume":"138","author":"Carr","year":"2024","journal-title":"Anesth Analg"},{"issue":"6","key":"2026080419562877200_zxag094-B32","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1097\/ALN.0000000000004174","article-title":"Quantitative neuromuscular monitoring in clinical practice: a professional practice change initiative","volume":"136","author":"Weigel","year":"2022","journal-title":"Anesthesiology"},{"key":"2026080419562877200_zxag094-B33","doi-asserted-by":"publisher","first-page":"100184","DOI":"10.1016\/j.pcorm.2021.100184","article-title":"Universal quantitative neuromuscular blockade monitoring at an academic medical center\u2014a multimodal analysis of the potential impact on clinical outcomes and total cost of care","volume":"24","author":"Edwards","year":"2021","journal-title":"Perioper Care Oper Room Manag"},{"issue":"2","key":"2026080419562877200_zxag094-B34","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/jac5.1185","article-title":"Perioperative clinical pharmacy practice: responsibilities and scope within the surgical care continuum","volume":"3","author":"Patel","year":"2020","journal-title":"J Am Coll Clin Pharm"},{"key":"2026080419562877200_zxag094-B35","doi-asserted-by":"publisher","DOI":"10.23937\/2377-4630\/1410067","article-title":"Interdisciplinary anesthesia tray revision project: reducing the opportunity for human error","volume":"14","author":"Smith","year":"2018","journal-title":"Int J Anesth Anesthesiol"},{"issue":"9","key":"2026080419562877200_zxag094-B36","doi-asserted-by":"publisher","first-page":"e68551","DOI":"10.7759\/cureus.68551","article-title":"Quantitative monitoring maximizes cost-saving strategies when antagonizing neuromuscular block with sugammadex","volume":"16","author":"Haberkorn","year":"2024","journal-title":"Cureus"},{"issue":"5","key":"2026080419562877200_zxag094-B37","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1213\/ANE.0000000000005842","article-title":"Sugammadex versus neostigmine for reversal of residual neuromuscular blocks after surgery: a retrospective cohort analysis of postoperative side effects","volume":"134","author":"Ruetzler","year":"2022","journal-title":"Anesth Analg"},{"issue":"1","key":"2026080419562877200_zxag094-B38","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.bja.2024.07.042","article-title":"Sugammadex hypersensitivity: a multicentre retrospective analysis of a large Australian cohort","volume":"134","author":"Crimmins","year":"2025","journal-title":"Br J Anaesth"},{"issue":"2","key":"2026080419562877200_zxag094-B39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4103\/joacp.JOACP_383_19","article-title":"Sugammadex and anaphylaxis: an analysis of 33 published cases","volume":"37","author":"Arslan","year":"2021","journal-title":"J Anaesthesiol Clin Pharmacol"},{"issue":"8","key":"2026080419562877200_zxag094-B40","doi-asserted-by":"publisher","first-page":"CD012763","DOI":"10.1002\/14651858.CD012763","article-title":"Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults","volume":"8","author":"Hristovska","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2026080419562877200_zxag094-B41","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jclinane.2017.11.003","article-title":"Cardiac arrest following anaphylaxis induced by sugammadex in a regional hospital","volume":"44","author":"Obara","year":"2018","journal-title":"J Clin Anesth"},{"issue":"1","key":"2026080419562877200_zxag094-B42","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.bja.2018.02.036","article-title":"Severe bradycardia and asystole after sugammadex","volume":"121","author":"Bhavani","year":"2018","journal-title":"Br J Anaesth"},{"issue":"2","key":"2026080419562877200_zxag094-B43","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1097\/ALN.0b013e31817f5bc7","article-title":"Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial","volume":"109","author":"P\u00fchringer","year":"2008","journal-title":"Anesthesiology"},{"issue":"4","key":"2026080419562877200_zxag094-B44","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.bja.2025.04.046","article-title":"Association of sugammadex, neostigmine, or pyridostigmine for reversal of neuromuscular block with postoperative bradycardia: a multicentre, retrospective observational study","volume":"135","author":"Kim","year":"2025","journal-title":"Br J Anaesth"},{"issue":"1","key":"2026080419562877200_zxag094-B45","doi-asserted-by":"publisher","first-page":"11179","DOI":"10.1038\/s41598-020-68164-2","article-title":"Assessment of the effects of sugammadex on coagulation profiles using thromboelastographic parameters","volume":"10","author":"Kang","year":"2020","journal-title":"Sci Rep"},{"issue":"9","key":"2026080419562877200_zxag094-B46","doi-asserted-by":"publisher","first-page":"824","DOI":"10.5414\/CP202145","article-title":"Effects of sugammadex on coagulation: it does not represent a bleeding risk in surgical patients","volume":"52","author":"Carron","year":"2014","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"1","key":"2026080419562877200_zxag094-B47","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12871-025-03041-x","article-title":"Effects of sugammadex on coagulation: a systematic review and meta-analysis","volume":"25","author":"Tsai","year":"2025","journal-title":"BMC Anesthesiol"},{"issue":"6","key":"2026080419562877200_zxag094-B48","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1097\/ALN.0000000000001076","article-title":"Anticoagulant effect of sugammadex: just an in vitro artifact","volume":"124","author":"Dirkmann","year":"2016","journal-title":"Anesthesiology"},{"issue":"1","key":"2026080419562877200_zxag094-B49","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.bja.2018.03.003","article-title":"Sugammadex-induced bradycardia and asystole: how great is the risk?","volume":"121","author":"Hunter","year":"2018","journal-title":"Br J Anaesth"},{"issue":"6","key":"2026080419562877200_zxag094-B50","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1213\/ANE.0000000000006442","article-title":"Sugammadex use for reversal in nonobstetric surgery during pregnancy: a reexamination of the evidence","volume":"136","author":"Gaston","year":"2023","journal-title":"Anesth Analg"},{"issue":"2","key":"2026080419562877200_zxag094-B51","doi-asserted-by":"publisher","first-page":"e01407","DOI":"10.1213\/XAA.0000000000001407","article-title":"Sugammadex administration in pregnant women: a case series of maternal and fetal outcomes","volume":"15","author":"Singh","year":"2021","journal-title":"AA Pract"},{"issue":"5","key":"2026080419562877200_zxag094-B52","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/bja\/aeq227","article-title":"Sugammadex reversal of rocuronium-induced neuromuscular block in caesarean section patients: a series of seven cases","volume":"105","author":"P\u00fchringer","year":"2010","journal-title":"Br J Anaesth"},{"issue":"2","key":"2026080419562877200_zxag094-B53","doi-asserted-by":"publisher","first-page":"114","DOI":"10.17085\/apm.23041","article-title":"What we need to know and do on sugammadex usage in pregnant and lactating women and those on hormonal contraceptives","volume":"18","author":"Do","year":"2023","journal-title":"Anesth Pain Med"},{"issue":"2","key":"2026080419562877200_zxag094-B54","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/ALN.0000000000005535","article-title":"Sugammadex for reversal of neuromuscular blockade in neonates and infants less than 2 years old: results from a phase IV randomized clinical trial","volume":"143","author":"Mensah-Osman","year":"2025","journal-title":"Anesthesiology"},{"issue":"6","key":"2026080419562877200_zxag094-B55","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1097\/ALN.0000000000005411","article-title":"Neuromuscular blockade and antagonism in patients with renal impairment: a multicenter retrospective cross-sectional study","volume":"142","author":"Elkhateb","year":"2025","journal-title":"Anesthesiology"},{"issue":"6","key":"2026080419562877200_zxag094-B56","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1097\/ALN.0000000000005475","article-title":"Sugammadex in chronic kidney disease: considerations regarding the safety and effectiveness of its frequent off-label use","volume":"142","author":"Thilen","year":"2025","journal-title":"Anesthesiology"},{"issue":"5","key":"2026080419562877200_zxag094-B57","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1213\/ANE.0000000000006807","article-title":"Sugammadex versus neostigmine for reversal of neuromuscular blockade in patients with severe renal impairment: a randomized, double-blinded study","volume":"138","author":"Oh","year":"2024","journal-title":"Anesth Analg"},{"issue":"9","key":"2026080419562877200_zxag094-B58","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/jac5.1762","article-title":"Perioperative medical emergencies: the role of clinical pharmacists and a review of pharmacotherapy considerations","volume":"6","author":"Hyland","year":"2023","journal-title":"J Am Coll Clin Pharm"},{"issue":"1","key":"2026080419562877200_zxag094-B59","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/ajhp\/zxae177","article-title":"Effect of pharmacist care on clinical outcomes and therapy optimization in perioperative settings: a systematic review","volume":"82","author":"Naseralallah","year":"2024","journal-title":"Am J Health-Syst Pharm"},{"issue":"2","key":"2026080419562877200_zxag094-B60","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.bja.2025.04.031","article-title":"Efficacy and safety of adamgammadex for reversing rocuronium-induced deep neuromuscular block: a multicentre, randomised, double-blind, positive-controlled phase III trial","volume":"135","author":"Zhao","year":"2025","journal-title":"Br J Anaesth"},{"issue":"6","key":"2026080419562877200_zxag094-B61","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1097\/ALN.0000000000000868","article-title":"Comparative effectiveness of calabadion and sugammadex to reverse non-depolarizing neuromuscular-blocking agents","volume":"123","author":"Haerter","year":"2015","journal-title":"Anesthesiology"},{"issue":"32","key":"2026080419562877200_zxag094-B62","doi-asserted-by":"publisher","first-page":"13313","DOI":"10.1002\/anie.202005902","article-title":"Pillar[n]MaxQ: a new high affinity host family for sequestration in water","volume":"59","author":"Xue","year":"2020","journal-title":"Agnew Chem Int Ed Engl"},{"issue":"6","key":"2026080419562877200_zxag094-B63","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.bja.2025.03.006","article-title":"Developing novel drugs to reverse neuromuscular block: do we need them?","volume":"134","author":"Hunter","year":"2025","journal-title":"Br J Anaesth"}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajhp\/advance-article-pdf\/doi\/10.1093\/ajhp\/zxag094\/67482138\/zxag094.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/83\/16\/835\/67482138\/zxag094.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajhp\/article-pdf\/83\/16\/835\/67482138\/zxag094.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:56:32Z","timestamp":1785887792000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/83\/16\/835\/8537508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":63,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,3,23]]},"published-print":{"date-parts":[[2026,8,5]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/zxag094","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8,15]]},"published":{"date-parts":[[2026,3,23]]}}}